Free shipping on all orders over $ 500

S217879

Cat. No. M42733

All AbMole products are for research use only, cannot be used for human consumption.

S217879 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

S217879 is a highly potent and selective NRF2 activator.

Chemical Information
Molecular Weight 578.64
Formula C29H30N4O7S
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Adel Hammoutene et al. JHEP Rep. A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease

[2] Klaus Seedorf et al. JHEP Rep. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice

Related Keap1-Nrf2 Products
CDDO-TFEA

CDDO-TFEA (RTA 404; TP-500) is a trifluoroacetamide derivative of CDDO with enhanced ability to cross the blood-brain barrier. CDDO is an Nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells. CDDO-TFEA can enhance Nrf2 expression and signaling in various neurodegenerative disease models.

KI696 isomer 

KI696 isomer is the less active isomer of KI696.

TAT-14

TAT-14 is a 14-mer peptide that acts as Nrf2 activator with an anti-inflammatory effect.

[D-Asp3]-Microcystin-LR

Microcystin-[D-Asp3]-LR/Microcystin A is a cyanotoxin.

Keap1-Nrf2 probe

Keap1-Nrf2 probe is a fluorescent Keap1-Nrf2 probe.

  Catalog
Abmole Inhibitor Catalog




Keywords: S217879 supplier, Keap1-Nrf2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.